Diabetes Exercise and Lifestyle Trial

NCT ID: NCT00877864

Last Updated: 2011-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine the effects of supervised combined aerobic and resistance training, and the effects of stage-matched written materials delivered by mail or internet, alone or in combination, on glycemic control as reflected in A1C (glycated hemoglobin).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Rationale: Structured, supervised exercise programs involving aerobic exercise, resistance exercise or their combination resulted in significant improvements in glycemic control in type 2 diabetes. It has also been shown that programs which include a psychological/behavioral component in addition to diet and exercise have been most effective for long-term treatment of obesity in diabetes. The supervised exercise program has stronger evidence for improvement of metabolic control and cardiac risk, but its longer-term sustainability has not been demonstrated, and it is relatively costly. A stage-matched printed materials/pedometer intervention has been shown to increase physical activity over a longer period of time, and likely at a lower per-patient cost than the supervised exercise intervention, but with less evidence for improvement of metabolic control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High volume combined aerobic/resistance exercise

Group Type ACTIVE_COMPARATOR

High volume combined aerobic/resistance exercise

Intervention Type BEHAVIORAL

High volume combined aerobic/resistance exercise

Low volume combined aerobic/resistance exercise

Low volume combined aerobic/resistance exercise

Group Type ACTIVE_COMPARATOR

Low volume combined aerobic/resistance exercise

Intervention Type BEHAVIORAL

Low volume combined aerobic/resistance exercise

High volume combined A/R exercise, printouts, pedometers

High volume combined aerobic/resistance exercise, printouts, pedometers

Group Type ACTIVE_COMPARATOR

High volume combined A/R exercise, printouts, pedometers

Intervention Type BEHAVIORAL

High volume combined aerobic/resistance exercise, printouts, pedometers

Low volume combined A/R exercise, printouts, pedometers

Low volume combined aerobic/resistance exercise, printouts, pedometers

Group Type ACTIVE_COMPARATOR

Low volume combined A/R exercise, printouts, pedometers

Intervention Type BEHAVIORAL

Low volume combined aerobic/resistance exercise, printouts, pedometers

Printed PA information, pedometers and step log group

Printed physical activity information, pedometers and step log group

Group Type ACTIVE_COMPARATOR

Printed PA information, pedometers and step log group

Intervention Type BEHAVIORAL

Printed PA information, pedometers and step log group

Control

Group Type PLACEBO_COMPARATOR

Control

Intervention Type BEHAVIORAL

No exercise program provided by the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High volume combined aerobic/resistance exercise

High volume combined aerobic/resistance exercise

Intervention Type BEHAVIORAL

Low volume combined aerobic/resistance exercise

Low volume combined aerobic/resistance exercise

Intervention Type BEHAVIORAL

High volume combined A/R exercise, printouts, pedometers

High volume combined aerobic/resistance exercise, printouts, pedometers

Intervention Type BEHAVIORAL

Low volume combined A/R exercise, printouts, pedometers

Low volume combined aerobic/resistance exercise, printouts, pedometers

Intervention Type BEHAVIORAL

Printed PA information, pedometers and step log group

Printed PA information, pedometers and step log group

Intervention Type BEHAVIORAL

Control

No exercise program provided by the study

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* type 2 diabetes
* A1c 0.700-0.099
* ability to read and write English
* signed ICF

Exclusion Criteria

* participation in previous 6 months in exercise \> 2 times per week for at least 20 min per session
* insulin therapy changes in medication for diabetes, BP or Lipids
Minimum Eligible Age

35 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Calgary

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Calgary

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ron Sigal, MD

Role: PRINCIPAL_INVESTIGATOR

University of Calgary

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Calgary

Calgary, Alberta, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHREB 22251

Identifier Type: -

Identifier Source: secondary_id

DEAL- 22251

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effort During Resistance Training in Type 2 Diabetes
NCT06497842 ACTIVE_NOT_RECRUITING NA